Prof. Qin Haifeng: new progress of combined treatment strategy for ASCO NSCLC Professor: deputy chief physician and associate professor of pulmonary oncology department of cancer center of the fifth medical center of PLA General Hospital; chairman of respiratory cancer adverse drug reaction management committee of Beijing Cancer Prevention and Control Association; Deputy Secretary General of precision medicine and Tumor Rehabilitation Professional Committee of China Association for promotion of rehabilitation technology transformation and development; tumor chemotherapy major of China Medical Education Association Member of the Standing Committee of the psychosomatic Committee of the Chinese Medicine Association of the whole army
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
